Neoadjuvant Goserelin for Triple Negative Breast Cancer

Clinical trial NCT03444025 · UNKNOWN

Trial details

NCT number: NCT03444025
Sponsor: Kasr El Aini Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Triple Negative

Start date: 2018-03-01
Primary completion: 2021-03-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.